Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Hungary Poland Romania +1
  • Study of Tocilizumab Subcutaneous Injection to Evaluate Bone Healing in Adult Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effectiveness and Safety of CT-P13 for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Poland
  • Study on Spironolactone for Treating Active Rheumatoid Arthritis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany
  • Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

    Not recruiting

    2 1 1 1
    Czechia Germany Hungary Italy The Netherlands Poland +1
  • Study on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Denmark Poland Romania
  • Study Comparing Abatacept and Adalimumab for Adults with Early Rheumatoid Arthritis Not Responding to Methotrexate

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Italy Poland Spain
  • Study on Methotrexate and Glucocorticoid Combination for Early Rheumatoid Arthritis, with Optional Etanercept for Non-Responders

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium
  • Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Estonia France Germany Hungary Italy +3